Research suggests creating influenza vaccines that only include the viral surface proteins would increase vaccine efficacy by preventing long-lived helper cells from generating and maintaining a suboptimal response. (IMAGE)
Caption
- Senior co-corresponding author Paul Thomas, PhD, St. Jude Department of Host-Microbe Interactions
Credit
Courtesy of St. Jude Children's Research Hospital
Usage Restrictions
none
License
Original content